Subsequent studies identified mice deficient for ENT3 that spontaneously developed anemia beginning at approximately 8 weeks, reaching severe mortality rates at approximately 18–20 weeks due to bone marrow failure [190,191]. Here, SLC29A3 is linked to anemia.